Novel Platforms to Assess the Cancer Continuom Using Liquid Biopsy
Christian Rolfo, MD, PhD, MBA, Dr.h.c.
Are The New Changes in Congress an Answer for Inequity in Terms of Access to Molecular Testing and New Cancer Agents?
Kashyap Patel, MD, ABOIM
Cost of Medications: How to Make Them Affordable—Are We on the Right Direction?
Dina Dumercy McHenry, PharmD, MBA, BCOP, CSSGB
Management of EGFR Mutant NSCLC Patients and Future Directions (excluding Resistance to EGFR TKIs)
Roy S. Herbst, MD, PhD, FACP, FASCO
Management of Metastatic Disease Using Interventional Radiology in 2023: Y90 SirSpheres and Other Procedures
Timothy Yates, MD
Most Common Adverse Events of Checkpoint Inhibitors | Current Recommendations and Management
Meri Tarockoff, MD
Immunotherapy in Advanced NSCLC: Initial Therapy and How to Overcome Resistance
George Simon, MD, FACP, FCCP
